5,8-二氯-1-四氢萘酮 | 112933-45-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 中文名称: 5,8-二氯-1-四氢萘酮
• 英文名称: 5,8-dichloro-3,4-dihydro-2H-naphthalen-1-one
• CAS: 112933-45-6
• 化学式: C₁₀H₈Cl₂O
• 分子量: 215.079
• InChiKey: ZWTJFNBFQPUZKF-UHFFFAOYSA-N

物化性质

• 熔点：
  39-41 °C
• 沸点：
  352.5±42.0 °C(Predicted)
• 密度：
  1.372±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5,8-二氯-1-四氢萘酮 在 sodium tetrahydroborate 、 四氧化锇 、 4 A molecular sieve 、 对甲苯磺酸 、 N-甲基吗啉氧化物 作用下， 以 乙醇 、 水 、 丙酮 、 甲苯 、 叔丁醇 为溶剂， 反应 39.5h， 生成 (-)-8-(5,8-Dichloro-1,2,3,4-tetrahydro-2-naphthyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one
  参考文献：
  名称：

  High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor

  摘要：

  The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro [4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized Ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro [4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro [4.5] decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors.

  DOI：

  10.1021/jm991129q
• 作为产物：
  描述：

  4,7-二氯-1-茚酮 在 triethyloxonium fluoroborate 作用下， 以 二氯甲烷 、 水 为溶剂， 240.0 ℃ 、1.7 MPa 条件下， 反应 2.5h， 生成 5,8-二氯-1-四氢萘酮
  参考文献：
  名称：

  High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor

  摘要：

  The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro [4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized Ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro [4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro [4.5] decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors.

  DOI：

  10.1021/jm991129q

文献信息

• A Novel Method for the Synthesis of Methyl Indane-1-carboxylates by Ring Contraction of Tetralones Using Lead(IV) Acetate
  作者：F. M. Nongrum、B. Myrboh

  DOI：10.1055/s-1987-28099

  日期：——

  A smooth ring contraction of the tetralones takes place with lead(IV) acetate in presence of boron trifluoride etherate and methanol to afford methyl indane-1-carboxylates in satisfactory yields. The method is extended to five- and seven-membered cyclic aromatic ketones.

  在三氟化硼醚化物和甲醇存在下，四氢萘酮与乙酸铅（IV）发生平滑的环收缩，从而得到茚-1-甲酸甲酯，产率令人满意。该方法可扩展到五元和七元环芳香酮。
• High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor
  作者：Stephan Röver、Geo Adam、Andrea M. Cesura、Guido Galley、François Jenck、Frederick J. Monsma,、Jürgen Wichmann、Frank M. Dautzenberg

  DOI：10.1021/jm991129q

  日期：2000.4.6

  The discovery of 8-(5,8-dichloro-1,2,3,4-tetrahydro-naphthalen-2-yl)-1-phenyl-1,3,8-triazaspiro [4.5]decan-4-one, 1a, as a high-affinity ligand for the human ORL1 (orphanin FQ/nociceptin) receptor led to the synthesis of a series of optimized Ligands. These compounds exhibit high affinity for the human ORL1 receptor, exhibit moderate to good selectivity versus opioid receptors, and behave as full agonists in biochemical assays. In this paper we present the synthesis, structure-activity relationship (SAR), and biochemical characterization of substituted 1-phenyl-1,3,8-triazaspiro [4.5]decan-4-ones culminating in the discovery of 8-(5-methyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-1-phenyl-1,3,8-triazaspiro [4.5] decan-4-one, 1p, and 8-acenaphten-1-yl-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one 1q, two high-affinity, potent ORL1 receptor agonists with good to moderate selectivity versus the other opioid receptors.